Lyo Cycle Development Ensures Success for Oncology Drug Scale-Up

Find out how engineering-led cycle development bridged the gap from benchtop to validated-scale up.

What works on a benchtop doesn’t always survive the jump to a large-scale lyophilizer. See how JHS engineers identified the root cause of a failed PPQ validation run and recovered the process without sacrificing cycle time.

What you’ll learn:

  • Why a failed pressure rise test stopped production
  • How a data-driven engineering review pinpointed the adjustment needed
  • The outcome: a robust, validated lyo cycle that passed all three PPQ batches
  • How isolator-based fill-finish with ALUS maintained sterility throughout

 

Lyophilizer

Related Posts

Increasing Batch Size and Reducing Cycle Times for a Biologic

Increasing Batch Size and Reducing Cycle Times for a Biologic

Challenge An existing partner wanted to work with JHS toinvestigate new ways to reduce the cycle time of abiologic product in order to serve more patients. Approach JHS has worked with this top 20 global pharmapartner for 15+ years on this drug product andsearched for...